Skip to main content
Clinical Trials/NCT03846089
NCT03846089
Withdrawn
Not Applicable

A Propensity Score Matched Pair Analysis of Retrograde Reperfusion Versus Antegrade Liver Transplant Reperfusion

London Health Sciences Centre0 sitesJanuary 1, 2002

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Transplant Failure
Sponsor
London Health Sciences Centre
Primary Endpoint
Graft survival
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

A retrospective cohort analysis was performed comparing patients that had intra operative antegrade liver reperfusions versus patients that had retrograde liver perfusion.

Detailed Description

A retrospective cohort analysis was performed comparing patients that had intra operative antegrade liver reperfusions versus patients that had retrograde liver perfusion. Antegrade Reperfusion(ATR) group: after completing the caval replacement or piggy-back, for IVC anastomosis, Portal vein (PV) anastomosis was done with a running suture as normal fashion, then it was followed by the removal the clamps, starting by the supra hepatic VC, followed by the PV clamp and finally the infrahepatic VC. It was followed by arterial anastomosis and the biliary anastomosis (duct-to-duct if possible). Retrograde group (RETR): after completing the piggyback the IVC was declamped immediately and retrograde low pressure reperfusion of the graft with low oxygenated venous blood was established. Central venous pressure was intended to be higher than in 8 mmHg to enable appropriate retrograde reperfusion in the transplanted liver. Significant venous backflow via portal vein appears immediately after declamping. Venous bleeding from the liver except portal backflow was stopped immediately after declamping the venous anastomosis, as appropriate. Portal vein anastomosis was performed using running suture. It was followed by arterial anastomosis and the biliary anastomosis (duct-to-duct if possible). The endpoints are patient survival and graft survival at 1, 3,5, 10 years post liver transplantation in both groups. To adjust for a selection bias, we will perform a propensity score analysis.

Registry
clinicaltrials.gov
Start Date
January 1, 2002
End Date
February 28, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Vivian McAlister

Professor of Surgery

London Health Sciences Centre

Eligibility Criteria

Inclusion Criteria

  • all liver transplantations between 1 Jan 2002 and 31 Dec 2005

Exclusion Criteria

  • liver retransplantation
  • multiorgan transplantation
  • ABO incompatible transplantation

Outcomes

Primary Outcomes

Graft survival

Time Frame: From date of transplantation until the date of next transplantation or date of death from any cause, whichever came first, assessed up to 300 months

Average length of time the liver graft remains in a living recipient regardless of function

Secondary Outcomes

  • Patient survival(From date of transplantation until the date of death from any cause assessed up to 300 months)

Similar Trials